PRA Health Sciences' GAAP net income for 3 months of 2021 was $56.94 million, up 40% from $40.66 million in the prior year. Revenue increased 19.1% to $933.755 million from $783.708 million a year earlier.

ICON is buying PRA Health Sciences for $12 billion. PRA shareholders will receive $80 and 0.4125 shares of ICON stock for each share of their company. As a result, they will own about 34% of the combined company. The deal is expected to close during Q3 2021.

PRA Health Sciences' GAAP net income for 2020 was $197.043 million, down 19% from $243.119 million the previous year. Revenues increased 3.8% to $3.183 billion from $3.066 billion a year earlier.

PRA Health Sciences' net profit under GAAP for 9 months of 2020 was $145.786 million, down 13.4% from $168.318 million the previous year. Revenue increased 1.9% to $2.31 billion, against $2.266 billion a year earlier.